Lunai Bioworks Inc. LNAI
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 21.81% | -42.90% | -163.83% | 102.22% | -67,083.19% |
| Total Depreciation and Amortization | 269.88% | -174.11% | -73.01% | 27.30% | 1.88% |
| Total Amortization of Deferred Charges | -85.66% | 23.75% | 116.22% | -- | -- |
| Total Other Non-Cash Items | -88.08% | 360.23% | 104.93% | -104.24% | 4,177.05% |
| Change in Net Operating Assets | -97.74% | -24.12% | -57.94% | -35.80% | 18.00% |
| Cash from Operations | -79.28% | 4.14% | 20.60% | 25.51% | -21.75% |
| Capital Expenditure | -- | 100.00% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -100.00% | -43.52% | 165.86% |
| Cash from Investing | -- | 100.00% | -100.22% | -43.52% | 165.86% |
| Total Debt Issued | -100.00% | 154.00% | -87.62% | -53.19% | 303.08% |
| Total Debt Repaid | 88.21% | -- | 100.00% | 0.00% | 0.00% |
| Issuance of Common Stock | -- | -100.00% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -87.81% | -- | -- | -- | -- |
| Cash from Financing | -89.35% | 289.84% | -29.28% | 653.03% | -95.02% |
| Foreign Exchange rate Adjustments | 136.92% | -21.50% | -57.35% | 95.80% | -663.68% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -154.12% | 2,099.70% | -125.03% | 164.09% | -235.85% |